SCHEMBL1992706

SCHEMBL1992706

CCN(CC)CCCS(=O)(=O)N[C@H](CCc1ccccc1)c1nc(-c2cccc(O)c2)n[nH]1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 1/20 0.72
HDAC3 O15379 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC10 Q969S8 1/20 0.40
HDAC11 Q96DB2 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
HDAC9 Q9UKV0 1/20 0.40
HDAC5 Q9UQL6 1/20 0.40
OPRK1 P41145 8/20 0.37
OPRM1 P35372 6/20 0.37
OPRD1 P41143 6/20 0.37
DRD2 P14416 4/20 0.37
DRD3 P35462 4/20 0.37
GAA P10253 1/20 0.34
F11 P03951 1/20 0.34
KLKB1 P03952 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1994335 0.91 GHSR (0.81) GHSRHDAC3HDAC4HDAC1HDAC7
SCHEMBL1996335 0.90 GHSR (0.72) GHSRHDAC3HDAC4HDAC1HDAC7
SCHEMBL1989790 0.90 GHSR (0.72) GHSRHDAC3HDAC4HDAC1HDAC7
SCHEMBL1992391 0.90 GHSR (0.72) GHSRHDAC3HDAC4HDAC1HDAC7
SCHEMBL1991593 0.89 GHSR (0.70) GHSRHDAC3HDAC4HDAC1HDAC7
SCHEMBL1993074 0.88 GHSR (0.69) GHSRHDAC3HDAC4HDAC1HDAC7
SCHEMBL1993917 0.85 GHSR (0.71) GHSRHDAC3HDAC4HDAC1HDAC7
SCHEMBL1981207 0.85 GHSR (0.81) GHSRHDAC3HDAC4HDAC1HDAC7
SCHEMBL1993722 0.85 GHSR (0.81) GHSRHDAC3HDAC4HDAC1HDAC7
SCHEMBL1981210 0.85 GHSR (0.81) GHSRHDAC3HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110152232-A1 SULFONAMIDE COMPOUNDS AND USES THEREOF SAUNDERS JEFFREY O 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152232-A1 SULFONAMIDE COMPOUNDS AND USES THEREOF GHSR, GHRHR, SSTR2 GHSR 1/4885HDAC3 299/4885HDAC4 575/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.